Suppr超能文献

抗真菌药物治疗口腔念珠菌病的疗效:贝叶斯网状Meta 分析。

Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis.

机构信息

Professor, Medical Department, Huadu District People's Hospital of Guangzhou, Guangdong, PR China.

Professor, The Institute of Metabolic Diseases, Baoan Central Hospital of Shenzhen, The Fifth Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, PR China.

出版信息

J Prosthet Dent. 2021 Feb;125(2):257-265. doi: 10.1016/j.prosdent.2019.12.025. Epub 2020 Mar 10.

Abstract

STATEMENT OF PROBLEM

The comparative efficacy of antifungal drugs on oral candidiasis remains unclear.

PURPOSE

The purpose of this Bayesian network meta-analysis was to investigate the efficacy of antifungal drugs on oral candidiasis.

MATERIAL AND METHODS

Databases, including PubMed, The Cochrane Library, and Web of Science, were accessed from the dates of their establishment to October, 2018, to collect randomized controlled trials (RCTs) of different antifungal drugs for oral candidiasis. A network meta-analysis was then conducted by using R and Stata 12.0 software programs.

RESULTS

A total of 31 RCTs involving 4042 participants were included. The meta-analysis showed that, in the treatment of oral candidiasis in reducing the mycological cure rate, itraconazole capsules, itraconazole oral solution, miconazole buccal tablets, miconazole oral gel, clotrimazole, fluconazole, ketoconazole, nystatin, and amphotericin B were better than a placebo. Miconazole oral gel, fluconazole, and ketoconazole were better than nystatin. The network meta-analysis also showed that the effects of antifungal drugs in reducing the mycological cure rate in oral candidiasis were better than those of a placebo: itraconazole capsule (OR=1.20, 95% CrI: 1.07-1.34), itraconazole oral solution (OR=1.50, 95% CrI: 1.14-1.86), miconazole buccal tablet (OR=2.80, 95% CrI: 1.20-4.50), miconazole oral gel (OR=2.90, 95% CrI: 1.70-4.30), clotrimazole (OR=3.80, 95% CrI: 1.65-5.95), fluconazole (OR=2.40, 95% CrI: 1.10-3.80), ketoconazole (OR=3.40, 95% CrI: 1.76-7.04), nystatin (OR=2.50, 95% CrI: 1.43-3.57), and amphotericin B (OR=2.60, 95% CrI: 1.91-3.29). The SUCRA values for each antifungal drug were as follows: placebo (6.80%), itraconazole capsule (51.2%), itraconazole oral solution (75.2%), miconazole buccal tablet (34.4%), miconazole oral gel (76.9%), clotrimazole (64.8%), fluconazole (79.3%), ketoconazole (50.7%), nystatin (15.7%), and amphotericin B (44.4%).

CONCLUSIONS

Antifungal drugs have efficacy in the treatment of oral candidiasis. The effect of fluconazole in reducing the risk of the mycological cure rate in oral candidiasis was better than that of other drugs.

摘要

问题陈述

抗真菌药物治疗口腔念珠菌病的疗效尚不清楚。

目的

本贝叶斯网状meta 分析旨在研究抗真菌药物治疗口腔念珠菌病的疗效。

材料和方法

从各数据库建立日期至 2018 年 10 月检索PubMed、The Cochrane Library 和 Web of Science 中关于不同抗真菌药物治疗口腔念珠菌病的随机对照试验(RCT),采用 R 和 Stata 12.0 软件程序进行网状meta 分析。

结果

共纳入 31 项 RCT 涉及 4042 名参与者。meta 分析显示,在降低口腔念珠菌病的微生物学治愈率方面,酮康唑、氟康唑、伊曲康唑胶囊、伊曲康唑口服液、克霉唑、咪康唑口腔凝胶、制霉菌素、两性霉素 B 优于安慰剂。咪康唑口腔凝胶、氟康唑和酮康唑优于制霉菌素。网状meta 分析还显示,抗真菌药物在降低口腔念珠菌病的微生物学治愈率方面优于安慰剂:酮康唑(OR=1.20,95% CrI:1.07-1.34)、伊曲康唑口服液(OR=1.50,95% CrI:1.14-1.86)、咪康唑口腔凝胶(OR=2.80,95% CrI:1.20-4.50)、克霉唑(OR=3.80,95% CrI:1.65-5.95)、氟康唑(OR=2.40,95% CrI:1.10-3.80)、酮康唑(OR=3.40,95% CrI:1.76-7.04)、制霉菌素(OR=2.50,95% CrI:1.43-3.57)、两性霉素 B(OR=2.60,95% CrI:1.91-3.29)。各抗真菌药物的 SUCRA 值如下:安慰剂(6.80%)、酮康唑(51.2%)、伊曲康唑口服液(75.2%)、咪康唑口腔凝胶(34.4%)、克霉唑(64.8%)、氟康唑(79.3%)、酮康唑(50.7%)、制霉菌素(15.7%)、两性霉素 B(44.4%)。

结论

抗真菌药物治疗口腔念珠菌病有效。氟康唑降低口腔念珠菌病微生物学治愈率的效果优于其他药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验